ADAM17 and COVID-19: Although our findings add to the understanding of COVID-19 pathophysiology, more studies are needed to investigate if the expression and activity of membrane-bound ADAM17 in human cells (such as peripheral blood leukocytes and bronchial epithelial cells) are associated with circulating ADAM17 and if ADAM17 activity can predict the outcome of SARS-CoV-2 infection.